Diffuse large B-cell lymphoma (DLBCL) remains the most common subtype of non-Hodgkin lymphoma (NHL). While frontline regimens such as R-CHOP and pola-R-CHP achieve cure in many patients, outcomes remain suboptimal for several presentations, including those with double- or triple-hit and activated B-cell type disease. Furthermore, many elderly or frail patients are ineligible for or cannot tolerate intensive frontline approaches. Despite incremental gains in frontline therapy, relapsed and refractory disease remains frequent, reflecting the limits of cytotoxic therapy in a molecularly heterogeneous cancer. To address these challenges, emerging targeted and cellular therapies including bispecific antibodies, CAR T-cell therapies, antibody drug conjugates, and investigational agents such as Bruton s tyrosine kinase inhibitors (BTKis) offer new opportunities to improve outcomes across treatment lines. However, this rapid pace of innovation presents ongoing challenges for oncology clinicians in integrating molecular data, sequencing therapeutic options, and managing unique toxicity profiles. This highly interactive, enduring activity uses a journal club-inspired format to share recent advances with practicing clinicians and to explore how these innovations are shaping care today and may do so in the future.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 201 King of Prussia Rd.
Pricing
CME included with membership
| Integrative Psychiatry Certificate Program | $3,350 |
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Addiction Psychiatry
- Adolescent Medicine
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Critical Care Medicine
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Otolaryngology
- General Pediatrics
- General Surgery
- Gynecologic Oncology
- Hematology
- Hospice & Palliative Medicine
- Medical Oncology
- Mood & Anxiety Disorders
- Neonatal-Perinatal Medicine
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Pain Medicine
- Physical Medicine & Rehabilitation
- Practice Management & Ethics
- Primary Care Sports Medicine
- Pulmonary Disease
- Radiation Oncology
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Urological Oncology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Rehabilitation
- Sports & Exercise Medicine
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 0.75 credits
- Commercial Support
-
ReleasedFeb 24, 2026
-
Last day to claim creditFeb 25, 2027 5 months left
-
Plexus Communications +1 Subtype-Driven Therapy in DLBCL: The Emerging Role of Frontline BTK Inhibition
-
PVI, PeerView Institute for Medical Education Adapting to Innovation in B-Cell Cancers: Advances With Targeted Therapy & CAR-T and Revisiting the Role of Transplant
-
PRIME Education, Inc. (PRIME®) Expert Strategies for Identifying Eligible Patients With DLBCL and FL for CAR T-Cell Therapy
-
Efficient CME, CME Outfitters, LLC What s Missing: A Microlearning Exploration of Gaps in the Management of Diffuse Large B-Cell Lymphoma and How Emerging Strategies Aim to Fill Them
-
Efficient CME, CME Outfitters, LLC Evidence in Action: Using Expert Insights and Practice Patterns to Guide Optimal Treatment of Chronic Lymphocytic Leukemia
-
Efficient CME, CME Outfitters, LLC From Gaps to Gains: A Microlearning Exploration of Persistent Challenges and Emerging Solutions in the Treatment of Adolescents and Adults with B-Cell Precursor Acute Lymphoblastic Leukemia
